Stefano Molica Selected Research

Stefano Molica Research Topics

Disease

73	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022 - 01/2002
17	Neoplasms (Cancer) 01/2021 - 11/2002
10	Disease Progression 12/2021 - 06/2003
8	Multiple Myeloma 10/2015 - 01/2002
6	Infections 10/2022 - 11/2012
6	Lymphocytosis 10/2015 - 07/2004
5	Residual Neoplasm 12/2021 - 10/2007
4	Anemia 04/2018 - 01/2002
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2017 - 08/2004
4	Hodgkin Disease (Hodgkin's Disease) 10/2017 - 12/2003
4	Leukemia 01/2015 - 07/2004
3	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 11/2016 - 01/2009
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2014 - 01/2005
2	COVID-19 01/2022 - 01/2021
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2018 - 05/2018
2	Hemorrhage 10/2018 - 10/2015
2	Atrial Fibrillation 10/2018 - 10/2015
2	Lymphoma (Lymphomas) 05/2018 - 10/2009
2	Primary Myelofibrosis (Myelosclerosis) 04/2018 - 08/2004
2	Breast Neoplasms (Breast Cancer) 01/2017 - 09/2003
2	Hematologic Neoplasms (Hematological Malignancy) 04/2012 - 07/2003
1	Agammaglobulinemia (Hypogammaglobulinemia) 08/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021
1	Trisomy (Trisomies) 06/2019
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2018
1	Thrombocytopenia (Thrombopenia) 05/2018
1	Diarrhea 05/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Agranulocytosis (Granulocytopenia) 01/2017
1	Cytopenia 11/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2015

Drug/Important Bio-Agent (IBA)

23	ibrutinibIBA 01/2022 - 10/2013
15	Biological ProductsIBA 06/2019 - 01/2006
12	Rituximab (Mabthera)FDA Link 12/2021 - 05/2014
7	fludarabineIBA 11/2020 - 05/2005
6	venetoclaxIBA 06/2021 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 04/2005
5	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 10/2013
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020 - 09/2002
4	Bendamustine Hydrochloride FDA Link 11/2020 - 11/2014
4	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2018 - 01/2008
4	Bleomycin (Blenoxane)FDA LinkGeneric 04/2009 - 09/2002
3	COVID-19 VaccinesIBA 08/2022 - 01/2022
3	obinutuzumabIBA 01/2021 - 01/2015
3	Chlorambucil (Leukeran)FDA Link 01/2017 - 05/2005
3	Alemtuzumab (Campath)FDA Link 02/2014 - 10/2007
3	Hemoglobins (Hemoglobin)IBA 01/2011 - 01/2002
3	Vinblastine (Vinblastine Sulfate)FDA Link 04/2009 - 12/2003
2	Messenger RNA (mRNA)IBA 03/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2021 - 11/2016
2	idelalisibIBA 01/2018 - 06/2015
2	Monoclonal AntibodiesIBA 01/2018 - 01/2017
2	Imatinib Mesylate (Gleevec)FDA Link 12/2017 - 04/2014
2	Brentuximab VedotinIBA 11/2017 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 03/2015 - 01/2015
2	Melphalan (Alkeran)FDA LinkGeneric 04/2014 - 09/2003
2	Bortezomib (Velcade)FDA Link 11/2012 - 01/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2009 - 01/2006
2	AdiponectinIBA 01/2009 - 11/2008
2	Prednisone (Sone)FDA LinkGeneric 01/2006 - 09/2002
2	Vincristine (Oncovin)FDA LinkGeneric 01/2006 - 09/2002
1	Immunoglobulin G (IgG)IBA 10/2022
1	BNT162 VaccineIBA 01/2022
1	acalabrutinibIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2020
1	ofatumumab FDA Link 11/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2019
1	Antiviral Agents (Antivirals)IBA 11/2018
1	AnticoagulantsIBA 10/2018
1	Pharmaceutical PreparationsIBA 10/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2018
1	Deferasirox FDA Link 04/2018
1	ruxolitinibIBA 04/2018
1	Glycoproteins (Glycoprotein)IBA 03/2018
1	Immunoglobulins (Immunoglobulin)IBA 03/2018
1	CD20 AntigensIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 12/2017
1	Lenalidomide (CC 5013)FDA Link 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	ublituximabIBA 01/2017
1	Thymidine KinaseIBA 01/2016
1	Biosimilar PharmaceuticalsIBA 10/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2015
1	Filgrastim (Neupogen)FDA Link 10/2015
1	betaglycan (TGFBR3)IBA 08/2015

Therapy/Procedure

33	Therapeutics 08/2022 - 01/2002
11	Drug Therapy (Chemotherapy) 01/2021 - 07/2003
3	Immunotherapy 05/2018 - 04/2014
2	Radiotherapy 04/2009 - 01/2006
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 07/2003 - 11/2002
1	Immunomodulation 10/2022
1	Time-to-Treatment 06/2019
1	Salvage Therapy 01/2018